Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2021
[Application of the « Junior Doctor » status in Radiation Oncology]V Bourbonne, M Michalet, H Lopez, et al.
Critical Reviews in Oncology/Hematology|February 19, 2005
Molecular prognostic factors in resectable non-small cell lung cancerP Vielh, J-P Spano, J Grenier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectivesJ P Spano, R Fagard, J-C Soria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2011
Added value of molecular targeted agents in oncologyJ C Soria, J Y Blay, J P Spano, et al.
Critical Reviews in Oncology/Hematology|September 17, 2017
Clinical pharmacology of anti-angiogenic drugs in oncologyP Gougis, J Wassermann, J P Spano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2005
Molecularly targeted agents: their promise as cancer chemopreventive interventionsA Thiery-Vuillemin, T Nguyen, X Pivot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 7, 2015
[Systemic treatment of brain metastases from lung cancer]F Barlesi, J-P Spano, A B Cortot, et al.
ESMO Open|October 31, 2024
Safety of solid oncology drugs in older patients: a narrative reviewA Rousseau, A Géraud, R Geiss, et al.
Breast (Edinburgh, Scotland)|April 28, 2015
Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORAJ-P Spano, P Beuzeboc, D Coeffic, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Nasopharyngeal carcinomas: an updateJ-P Spano, P Busson, D Atlan, et al.
Pageof 5